Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

Tissue Engineering Part A is a prestigious peer-reviewed journal published by MARY ANN LIEBERT, INC that focuses on innovative research and advancements within the field of tissue engineering and regenerative medicine. Since its inception in 2008, this journal has played a critical role in disseminating cutting-edge findings that bridge the gap between laboratory research and clinical application, underscoring its significance in the scientific community. With a diverse scope encompassing biochemistry, bioengineering, biomaterials, and biomedical engineering, the journal ranks notably in the Scopus database, holding a Q2 quartile status across multiple categories, thus reflecting its high impact on ongoing research and professional practice. For researchers, professionals, and students, Tissue Engineering Part A serves as an invaluable resource, offering insights into the latest methodologies and breakthroughs that drive the future of healthcare and therapeutic strategies. While primarily a subscription-based journal, it ensures that vital research is accessible to a broad audience of scientists and engineers committed to advancing the life sciences.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

CELL AND TISSUE BANKING, published by Springer, is a prominent journal dedicated to advancing the fields of biomaterials, biomedical engineering, cell biology, and transplantation. With its ISSN 1389-9333 and E-ISSN 1573-6814, the journal plays a crucial role in disseminating high-quality research from its inception in 2000 to its ongoing contributions through 2024. Situated in the Netherlands, it boasts a respectable 2023 impact factor with notable quartile rankings, positioning it within the Q3 category for biomaterials, biomedical engineering, and transplantation, and Q4 for cell biology. Furthermore, its Scopus rankings underscore its relevance and influence, particularly in the fields of medicine and engineering. Although it does not currently offer open access options, the journal remains a vital resource for researchers, professionals, and students alike, fostering innovation and knowledge transfer in the critical areas of cell and tissue sustainability.

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.

Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.